2026 Annual Meeting | S28 - Neuro-oncology: Clinical and Practice Updates

Date Tuesday 04/21/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Location McCormick Place West | W192a

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Alissa A. Thomas, MD, FAAN, Maya S. Graham, MD

Topic(s) Neuro-oncology

CME Available 2.00 CME credits

Program Tracks Advanced Practice Provider

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM CDT	Speaker	2026 Neuro-oncology Scientific Award: This award recognizes an individual from any discipline and of any academic rank for a singular scientific achievement that has advanced the field of neuro-oncology Terri S. Armstrong, PhD, ANP-BC
03:42 PM - 03:54 PM CDT	Abstract	002 - Exploratory Analyses from the Phase Three INDIGO Study Suggest Potential Mechanism of Seizure Control Through Tumor Volume Reduction Under Treatment With Vorasidenib Katherine B. Peters, MD, PhD, FAAN
03:54 PM - 04:06 PM CDT	Abstract	003 - Response to Next Intervention After Off-label Ivosidenib Treatment Failure in Patients With Mutant IDH Low Grade Glioma Maria A. Minor, MD
04:06 PM - 04:18 PM CDT	Abstract	004 - Efficacy, Tolerability, and Safety of Cenobamate in Adult Patients With Supratentorial Brain Tumor Related Epilepsy: A Single Center Study Gira I. Graciano Mireles, MD
04:18 PM - 04:30 PM CDT	Abstract	005 - Tumor Inflammation Associated Neurotoxicity (TIAN) is Associated With Improved Outcomes in CNS Lymphoma Treated With CD19-CAR T-cell Therapy Jorg Dietrich, MD, PhD, FAAN
04:30 PM - 04:42 PM CDT	Abstract	006 - Catechol-O-Methyltransferase (COMT) Genotypes and Cognitive Resilience in Patients With Primary Brain Tumors Kristin Bartman, MD
04:42 PM - 04:54 PM CDT	Abstract	007 - COPAL CNS: A Delphi Developed Core Outcome Set of Patient-reported Outcomes for PALliative Care Interventions in Adults Living With Primary CNS Cancer by a Global Interdisciplinary and Patient Stakeholder Group Akanksha Sharma, MD
04:54 PM - 05:06 PM CDT	Abstract	008 - Analyzing Cultural Preferences to Improve Patient Satisfaction in Neuro-oncologic Care Jigisha Thakkar, MD
05:06 PM - 05:18 PM CDT	Abstract	009 - Metabolomic and Lipidomic Profiling Reveals Distinct Subtypes of IDH-wildtype Glioblastoma and Shared Metabolic Features with IDH-mutant Astrocytoma Grade Four John Paul Aboubechara, MD, PhD
05:18 PM - 05:30 PM CDT	Abstract	010 - GLP-1 Receptor Agonists and Neurological Outcomes in Patients With Brain Tumors: A Real-world Propensity-matched Cohort Study Seerat Sachdeva, MD

Faculty Disclosures
Jonathan Dewey	Dr. Dewey has received personal compensation for serving as an employee of Servier Pharmaceuticals.
Warren P. Mason, MD, FAAN	Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Ingelheim. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Therapeutics.
Maya S. Graham, MD	The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
John Y. Rhee, MD, MPH	Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from American Academy of Neurology. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.
Isaac Ng	Mr. Ng has nothing to disclose.
Oliver Fiehn	Oliver Fiehn has nothing to disclose.
Kelli C. Manthei	Ms. Manthei has nothing to disclose.
Henry Friedman	No disclosure on file
Mehdi Touat, MD	Dr. Touat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for servier. Dr. Touat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novocure. Dr. Touat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for servier. Dr. Touat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novocure. The institution of Dr. Touat has received research support from sanofi.
Heather Leeper, MD	Dr. Leeper has nothing to disclose.
Lori Steelman	Lori Steelman has received personal compensation for serving as an employee of Servier Pharmaceuticals.
Leon D. Kaulen, MD	Dr. Kaulen has nothing to disclose.
Derek A. Wainwright, PhD	Prof. Wainwright has nothing to disclose.
Kevin Barton, MD	Dr. Barton has nothing to disclose.
Kristen A. Batich, PhD	Kristen Batich has nothing to disclose.
Jacob Soumerai	No disclosure on file
Scott R. Plotkin, MD, PhD, FAAN	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Jennifer Philip, MBBS, PhD	The institution of Prof. Philip has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Philip has received research support from Cancer Council Victoria.
Liam Welsh, MD, MBBS, PhD	Dr. Welsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Welsh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Katherine B. Peters, MD, PhD, FAAN	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.
Edward Avila, DO, FAAN	Dr. Avila has received publishing royalties from a publication relating to health care.
John Paul Aboubechara, MD, PhD	Dr. Aboubechara has nothing to disclose.
Emily Schein, Student	Miss Schein has nothing to disclose.
Annick DesJardins, MD	Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biodexa. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chimerix. Dr. DesJardins has stock in Istari Oncology. Dr. DesJardins has received intellectual property interests from a discovery or technology relating to health care.
Mary Lou Affronti, NP	Dr. Affronti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Society for Neuro-Oncology. Dr. Affronti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for of the Multinational Association of Supportive Care in Cancer . The institution of Dr. Affronti has received research support from TerSera.
Justin T. Low, MD, PhD	Dr. Low has nothing to disclose.
Gira I. Graciano Mireles, MD	Dr. Graciano Mireles has nothing to disclose.
Mustafa Khasraw, MD	No disclosure on file
Lina Dahabiyeh, PhD	Prof. Dahabiyeh has nothing to disclose.
Rudra Pratap Singh, MD	Dr. SINGH has nothing to disclose.
Marcela Maus, MD, PhD	Dr. Maus has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for A2Bio (SAB). Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for Adaptimmune. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for AstraZeneca. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio (SAB). Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for In8bio (SAB). Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for KSQ. Dr. Maus has received personal compensation in the range of $0-$499 for serving as a Consultant for Lumicks. Dr. Maus has stock in Model T bio. The institution of Dr. Maus has received research support from Kite Pharma. The institution of Dr. Maus has received research support from Sobi. Dr. Maus has received intellectual property interests from a discovery or technology relating to health care. Dr. Maus has received intellectual property interests from a discovery or technology relating to health care.
Jeremy Abramson	Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Interius. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra-Zeneca. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Foresight Diagnostics. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi Biotec. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BeiGene. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Jeremy Abramson has received research support from Allogene. The institution of Jeremy Abramson has received research support from BMS. The institution of Jeremy Abramson has received research support from Genentech. Jeremy Abramson has received research support from Cellectis. The institution of Jeremy Abramson has received research support from Merck.
Martin Van Den Bent	Martin Van Den Bent has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fore Biotherapeutics. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Cancer. Martin Van Den Bent has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuro-Oncology.
Rawad Hodeify	Rawad Hodeify has nothing to disclose.
Shariq M. Zaman	Mr. Zaman has nothing to disclose.
Sofia Doubrovinskaia	No disclosure on file
Philipp Karschnia	Philipp Karschnia has nothing to disclose.
Divya Singh, Student	Ms. Singh has nothing to disclose.
Ingo K. Mellinghoff, MD, FACP	Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca .
Vansh M. Patel, MBBS	Mr. Patel has nothing to disclose.
David Q. Mao, MD	Dr. Mao has nothing to disclose.
Vikram Prabhu	Vikram Prabhu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss.
Felix Ehret, MD	Dr. Ehret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accuray. The institution of Dr. Ehret has received research support from Accuray. Dr. Ehret has received research support from German Cancer Aid.
Jianing Yi	Miss Yi has nothing to disclose.
Orwa Aboud, MD, PhD	Dr. Aboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aboud LLC.
Julia Walker, PhD	The institution of Dr. Walker has received research support from NIAID.
Tracy T. Batchelor, MD, MPH	Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Eirena Calabrese, NP	Mrs. Calabrese has nothing to disclose.
Dan Zhao	Dan Zhao has nothing to disclose.
Melinda Miculinich, RN	Mrs. Miculinich has nothing to disclose.
Matthew Frigault	No disclosure on file
Kristin Bartman, MD	Dr. Bartman has nothing to disclose.
Jeff Barnes	No disclosure on file
Jenil Patel, PhD	Dr. Patel has nothing to disclose.
Terri S. Armstrong, PhD, ANP-BC	Dr. Armstrong has nothing to disclose.
Johan A. Koekkoek, MD	The institution of Mr. Koekkoek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. The institution of Mr. Koekkoek has received research support from ZonMw.
Isabella Milejczyk, BS, MA	Miss Milejczyk has nothing to disclose.
Wolfgang Wick	The institution of Wolfgang Wick has received research support from Roche. The institution of Wolfgang Wick has received research support from Pfizer. The institution of Wolfgang Wick has received research support from Apogenix.
Riccardo Soffietti, MD	Dr. Soffietti has nothing to disclose.
Andreas F. Hottinger, MD	The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novocure. The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure.
Jennifer L. Clarke, MD, MPH	The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Clarke has received research support from Agios. The institution of Dr. Clarke has received research support from Servier. The institution of Dr. Clarke has received research support from Merck.
Patrick Y. Wen, MD, FAAN	Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
Katherine S. Panageas, PhD	Dr. Panageas has nothing to disclose.
Iffat Ara Suchita, MD	Dr. Suchita has nothing to disclose.
Andrew Pickles, Medical Student	Mr. Pickles has nothing to disclose.
Deborah T. Blumenthal, MD	Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Affaires Medicales. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure Israel Ltd. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Oncology. The institution of Dr. Blumenthal has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck Sharp and Dohme.
Anne S. Reiner	Mrs. Reiner has nothing to disclose.
Seerat Sachdeva, MD	Dr. Sachdeva has nothing to disclose.
Daniel Weidl, PhD	Dr. Weidl has received personal compensation for serving as an employee of Servier .
Ruben Fragoso	Ruben Fragoso has nothing to disclose.
Yingchun Zhang	Dr. Zhang has received personal compensation for serving as an employee of Daiichi Sankyo (China) Holding Co., Ltd..
David Ashley	No disclosure on file
Jorg Dietrich, MD, PhD, FAAN	Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Sooin Choi	Miss Choi has nothing to disclose.
Ephraim Hochberg	No disclosure on file
Areej El-Jawahri	Areej El-Jawahri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Incyte Corporation.
Islam Hassan	Islam Hassan has received personal compensation for serving as an employee of Servier pharmaceuticals.
Rana Elkholi	No disclosure on file
Connor Johnson	No disclosure on file
L. Nicolas Gonzalez Castro, MD, PhD, FAAN	Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Gonzalez Castro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishing. Dr. Gonzalez Castro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ Best Practice. Dr. Gonzalez Castro has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. An immediate family member of Dr. Gonzalez Castro has or had stock in Takeda. The institution of Dr. Gonzalez Castro has received research support from Merck & Co.
Deborah H. Allen, PhD, RN, NP	Dr. Allen has nothing to disclose.
Maria Martinez-Lage, MD	The institution of Dr. Martinez-Lage has received research support from NIH.
Jonathan Riess	Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Jonathan Riess has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi Sankyo. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SeaGen. Jonathan Riess has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Riess has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Orin Bloch	Orin Bloch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris Medical. Orin Bloch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BrainLab. The institution of Orin Bloch has received research support from NIH.
Madison Shoaf, MD	Dr. Shoaf has nothing to disclose.
Margaret O. Johnson, MD	Dr. Johnson has nothing to disclose.
Maria A. Minor, MD	Dr. Minor has nothing to disclose.
Ganesh Shankar	Ganesh Shankar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Depuy. The institution of Ganesh Shankar has received research support from NuVasive.
Timothy F. Cloughesy, MD	Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vida Ventures. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lista Therapeutics. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stemline. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sonalasense. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jubilant. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gan & Lee. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainstorm. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Cloughesy has received personal compensation in the range of $0-$499 for serving as a Consultant for Inovio. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DNATrix. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tyme. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kintara. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Katmai. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Break Through Cancer. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kintara. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Katmai. Dr. Cloughesy has stock in Katmai. Dr. Cloughesy has stock in Chimerix. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care.
Lalanthica Yogendran, MD	The institution of Dr. Yogendran has received research support from Incyte. The institution of Dr. Yogendran has received research support from Dana Farber . The institution of Dr. Yogendran has received research support from FALK Catalyst. Dr. Yogendran has received personal compensation in the range of $0-$499 for serving as a speaker at community conference with Parkinson Support and Wellness. Dr. Yogendran has received personal compensation in the range of $500-$4,999 for serving as a speaker at local conference with University of Cincinnati.
Yi-Bin Chen	No disclosure on file
Juan Manuel Sanchez	Juan Manuel Sanchez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Juan Manuel Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servie. Juan Manuel Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Joe S. Mendez, MD	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cohne Kinghorn.
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Alissa A. Thomas, MD, FAAN	The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Yin A. Liu, MD, FAAN	Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Alicia T. Savelli, RN	Miss Savelli has nothing to disclose.
Jigisha Thakkar, MD	Dr. Thakkar has nothing to disclose.